Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | ACP3 | P15309 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.53 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28149096 | 0.98 | TDP1 (0.61) | TDP1ACP3CYP1A2CYP2C19CYP2D6 | |
| SCHEMBL30365968 | 0.95 | CYP1A2 (0.59) | TDP1ACP3CYP1A2CYP2C19CYP2D6 | |
| SCHEMBL47 | 0.95 | CYP1A2 (0.59) | TDP1ACP3CYP1A2CYP2C19CYP2D6 | |
| Acetic Acid SCHEMBL31090370 | 0.94 | TDP1 (0.63) | TDP1ACP3CYP1A2CYP2C19CYP2D6 | |
| Acetic Acid SCHEMBL5802343 | 0.94 | TDP1 (0.63) | TDP1ACP3CYP1A2CYP2C19CYP2D6 | |
| Hydrogen Sulfide SCHEMBL28763519 | 0.93 | CYP1A2 (0.57) | TDP1ACP3CYP1A2CYP2C19CYP2D6 | |
| Water SCHEMBL8463988 | 0.93 | CYP1A2 (0.57) | TDP1ACP3CYP1A2CYP2C19CYP2D6 | |
| Phosphine SCHEMBL28240107 | 0.93 | CYP1A2 (0.57) | TDP1ACP3CYP1A2CYP2C19CYP2D6 | |
| SCHEMBL29140496 | 0.93 | CYP1A2 (0.57) | TDP1ACP3CYP1A2CYP2C19CYP2D6 | |
| Naphthalene SCHEMBL28758695 | 0.93 | CYP1A2 (0.57) | TDP1ACP3CYP1A2CYP2C19CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023132551-A1 | SAND FOR DIAGNOSING STATE OF ANIMAL URINE, METHOD FOR MANUFACTURING SAME, AND URINE STATE DIAGNOSIS METHOD USING SAME | 주식회사 퓨쳐바이오웍스 | 2023-07-13 | — | — | WO | claimed |
| EP-3237365-B1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | RHODIA OPERATIONS (FR) | 2018-11-28 | — | — | EP | claimed |
| CN-105339332-B | Cycloalkanes oxidation catalyst and the method for production alcohol and ketone | 罗地亚经营管理公司 | 2018-04-10 | — | — | CN | claimed |
| EP-2877439-B1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | RHODIA OPERATIONS (FR) | 2018-02-14 | — | — | EP | claimed |
| US-20170349524-A1 | Cycloalkane oxidation catalysts and method to produce alcohols and ketones | BASF SE (DE) | 2017-12-07 | — | — | US | claimed |
| EP-3237365-A1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | Rhodia Operations (FR) | 2017-11-01 | — | — | EP | claimed |
| US-9745239-B2 | Cycloalkane oxidation catalysts and method to produce alcohols and ketones | RHODIA OPERATIONS (FR) | 2017-08-29 | — | — | US | claimed |
| CN-107108414-A | Cycloalkane oxidation catalyst and process for producing alcohol and ketone | 罗地亚经营管理公司 | 2017-08-29 | — | — | CN | claimed |
| US-9708238-B2 | Cycloalkane oxidation catalysts and method to produce alcohols and ketones | RHODIA OPERATIONS (FR) | 2017-07-18 | — | — | US | claimed |
| EP-2986585-B1 | CYCLOALKANE OXIDATION CATALYSTS AND METHOD TO PRODUCE ALCOHOLS AND KETONES | RHODIA OPERATIONS (FR) | 2017-06-21 | — | — | EP | claimed |
| US-20040122243-A1 | Process for oxidizing carbon-carbon double bond and process for producing oxidized compounds | SHOWA DENKO K.K. (JP) | 2004-06-24 | — | — | US | claimed |
| US-20040034258-A1 | Crystalline MWW-type titanosilicate catalyst for producing oxidized compound, production process for the catalyst, and process for producing oxidized compound by using the catalyst | SHOWA DENKO K.K. | 2004-02-19 | — | — | US | claimed |
| US-6646102-B2 | Epoxidizing an alpha - halohydrin intermediate produced from a halide substitution of an alpha -dihydroxy derivative which has been obtained by a dihydroxylation reaction of an aryl allyl ether, oxidation catalysts | DOW GLOBAL TECHNOLOGIES INC. | 2003-11-11 | — | — | US | claimed |
| WO-2003074421-A1 | TITANOSILICATE, PROCESS FOR ITS PRODUCTION, AND ITS USE IN PRODUCING OXIDIZED COMPOUND | SHOWA DENKO K. K. (JP) | 2003-09-12 | — | — | WO | claimed |
| EP-1324948-A2 | CRYSTALLINE MWW-TYPE TITANOSILICATE, ITS PREPARATION AND USE THEREOF FOR PRODUCING EPOXIDES | Showa Denko K.K. (JP) | 2003-07-09 | — | — | EP | claimed |
| US-20030105268-A1 | Process for manufacturing an alpha-dihydroxy derivative and epoxy resins prepared therefrom | DOW GLOBAL TECHNOLOGIES INC. | 2003-06-05 | — | — | US | claimed |
| US-20030040649-A1 | Crystalline mww-type titanosilicate catalyst for producing oxidized compound, production process for the catalyst, and process for producing oxidized compound by using the catalyst | SHOWA DENKO K.K. (JP) | 2003-02-27 | — | — | US | claimed |
| US-6500955-B1 | CONDENSING A HALO- QUINOLINE WITH AN ALPHA-PICOLYL DERIVATIVES IN THE PRESENCE OF A SOLVENT AND A PHASE TRANSFER CATALYST AT -10 TO 90 DEGREE C. TO FORM (2,8-BIS (TRIFLUOROMETHYL)-4-QUINOLINYL)-2-PYRIDINYLMETHANONE | NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (IN) | 2002-12-31 | — | — | US | claimed |
| US-20020188129-A1 | ONE POT SYNTHESIS OF [2, 8-BIS (TRIFLUOROMETHYL)-4- QUINOLINYL]2-PYRIDINYLMETHANONE, A MEFLOQUINE INTERMEDIATE | NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (IN) | 2002-12-12 | — | — | US | claimed |
| WO-2002028774-A2 | CRYSTALLINE MWW-TYPE TITANOSILICATE , ITS PREPARATION AND USE THEREOF FOR PRODUCING EPOXIDES | SHOWA DENKO K. K. (JP) | 2002-04-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020188129-A1 | ONE POT SYNTHESIS OF [2, 8-BIS (TRIFLUOROMETHYL)-4- QUINOLINYL]2-PYRIDINYLMETHANONE, A MEFLOQUINE INTERMEDIATE | EIF2AK2, POLK, QARS1 | TDP1 1543/4885ACP3 4246/4885CYP1A2 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.